Literature DB >> 2674690

Autoregulation of interleukin 6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells.

Y Shabo1, J Lotem, L Sachs.   

Abstract

Induction of differentiation in one type of clone of mouse myeloid leukemic cells by mouse or human interleukin 6 (IL-6) and in another type of clone by mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) was found to be associated with induction of IL-6 and GM-CSF mRNA and protein. The results indicated that IL-6 and GM-CSF could positively autoregulate their own gene expression during myeloid cell differentiation. It is suggested that this autoregulation may serve to enhance and prolong the signal induced by these proteins in cells transiently exposed to IL-6 or GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674690      PMCID: PMC362483          DOI: 10.1128/mcb.9.9.4109-4112.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

4.  Genetic dissection of the control of normal differentiation in myeloid leukemic cells.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  Differentiation of a cell line of myeloid leukemia.

Authors:  Y Ichikawa
Journal:  J Cell Physiol       Date:  1969-12       Impact factor: 6.384

6.  Control of lysozyme induction in the differentiation of myeloid leukemic cells.

Authors:  A Krystosek; L Sachs
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes.

Authors:  E Fibach; M Hayashi; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

9.  Separation of different molecular forms of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells.

Authors:  J Lotem; J H Lipton; L Sachs
Journal:  Int J Cancer       Date:  1980-06-15       Impact factor: 7.396

10.  Characterization of macrophage- and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor.

Authors:  J H Lipton; L Sachs
Journal:  Biochim Biophys Acta       Date:  1981-04-03
View more
  9 in total

Review 1.  Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound Regeneration.

Authors:  Carlos Zgheib; Junwang Xu; Kenneth W Liechty
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

2.  Differentiation of the rat myelomonocytic leukemia cell line c-WRT-7 by in vitro culture with the rat bone marrow preadipocyte cell line REC A16.

Authors:  T Tanaka; S Okamura; S Yasumoto; N Takeichi; H Kobayashi; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 3.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

Review 4.  The control of hematopoiesis and leukemia: from basic biology to the clinic.

Authors:  L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line.

Authors:  J D Bretz; S C Williams; M Baer; P F Johnson; R C Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

Review 6.  Interleukin-6 in clinical medicine.

Authors:  J Bauer; F Herrmann
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

7.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

8.  eIF4A inhibition prevents the onset of cytokine-induced muscle wasting by blocking the STAT3 and iNOS pathways.

Authors:  Zvi Cramer; Jason Sadek; Gabriela Galicia Vazquez; Sergio Di Marco; Arnim Pause; Jerry Pelletier; Imed-Eddine Gallouzi
Journal:  Sci Rep       Date:  2018-05-30       Impact factor: 4.379

Review 9.  Recent Advances in Electrochemical and Optical Biosensors Designed for Detection of Interleukin 6.

Authors:  Munezza Ata Khan; Mohammad Mujahid
Journal:  Sensors (Basel)       Date:  2020-01-23       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.